Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Waylan Bessler
Exth-13. Reduction of Tumor Burden and Hearing Loss With a Multiple Receptor Tyrosine Kinase Inhibitor Brigatinib in a Genetically Engineered Mouse Model of Neurofibromatosis Type 2
Neuro-Oncology
Cancer Research
Oncology
Neurology
Related publications
Chemopreventative Celecoxib Fails to Prevent Schwannoma Formation or Sensorineural Hearing Loss in Genetically Engineered Murine Model of Neurofibromatosis Type 2
Oncotarget
Oncology
Adrenal Tumor Volume in a Genetically Engineered Mouse Model of Neuroblastoma Determined by Magnetic Resonance Imaging
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma
PLoS ONE
Multidisciplinary
The Bruton’s Tyrosine Kinase Inhibitor Acalabrutinib Protects From Anaphylaxis in a Humanized Mouse Model
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Multiple Roles for the Receptor Tyrosine Kinase Axl in Tumor Formation
Cancer Research
Cancer Research
Oncology
Bioluminescent Approaches for Measuring Tumor Growth in a Mouse Model of Neurofibromatosis
Toxicologic Pathology
Forensic Medicine
Toxicology
Pathology
Cell Biology
Molecular Biology
Tyrosine Kinase Inhibitor NVP-BGJ398 Functionally Improves FGFR3-related Dwarfism in Mouse Model
Journal of Clinical Investigation
Medicine
Effector T Cell Subclasses Associate With Tumor Burden in Neurofibromatosis Type 1 Patients
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Hair Depigmentation During Chemotherapy With a Class III/V Receptor Tyrosine Kinase Inhibitor
Archives of Dermatology
